LNWTC
PRCT icon

Laird Norton Wetherby Trust Company’s Procept Biorobotics PRCT Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,339
Closed -$720K – 123
2022
Q4 		$720K Sell
17,339
-38,122
-69% -$1.64M 0.1% 47
2022
Q3 		$2.3M Sell
55,461
-24,000
-30% -$957K 0.52% 24
2022
Q2 		$2.6M Buy
+79,461
New +$2.89M 0.33% 25

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Laird Norton Wetherby Trust Company's PRCT Position: Q1 2023 in Review

Laird Norton Wetherby Trust Company sold out of Procept Biorobotics (PRCT) in Q1 2023, closing a stake of 17,339 shares — an estimated $720K sold.

Laird Norton Wetherby Trust Company first reported a position in PRCT in Q2 2022 and held it in 3 quarters. The position peaked at $2.6M in Q2 2022. 116 funds tracked by Wall St. Rank hold PRCT as of Q1 2023.

  • Laird Norton Wetherby Trust Company reported no remaining Procept Biorobotics position as of Q1 2023 after selling out during the quarter.
  • Laird Norton Wetherby Trust Company sold 17,339 Procept Biorobotics shares in Q1 2023, an estimated $720K.
  • Laird Norton Wetherby Trust Company first reported a position in Procept Biorobotics in Q2 2022 and held it in 3 quarters.
  • Laird Norton Wetherby Trust Company's Procept Biorobotics position peaked at $2.6M in Q2 2022.
  • 116 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2023.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2023, filed 15 May 2023.